{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T11:40:00Z","timestamp":1787139600888,"version":"build-2736575974"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T00:00:00Z","timestamp":1554336000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12944-019-1014-7","type":"journal-article","created":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T15:04:10Z","timestamp":1554390250000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Association between skeletal muscle mass and serum concentrations of lipoprotein lipase, GPIHBP1, and hepatic triglyceride lipase in young Japanese men"],"prefix":"10.1186","volume":"18","author":[{"given":"Ryutaro","family":"Matsumoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6119-4158","authenticated-orcid":false,"given":"Katsuhiko","family":"Tsunekawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Shoho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimaro","family":"Yanagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuo","family":"Kotajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Araki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyuki","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,4]]},"reference":[{"key":"1014_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0070-2153(05)68005-2","volume":"68","author":"H Karakelides","year":"2005","unstructured":"Karakelides H, Nair KS. Sarcopenia of aging and its metabolic impact. Curr Top Dev Biol. 2005;68:123\u201348.","journal-title":"Curr Top Dev Biol"},{"key":"1014_CR2","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1002\/jcb.25077","volume":"116","author":"TN Kim","year":"2015","unstructured":"Kim TN, Choi KM. The implications of sarcopenia and sarcopenic obesity on cardiometabolic disease. J Cell Biochem. 2015;116:1171\u20138.","journal-title":"J Cell Biochem"},{"key":"1014_CR3","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s40618-013-0011-3","volume":"37","author":"SJ Baek","year":"2014","unstructured":"Baek SJ, Nam GE, Han KD, Choi SW, Jung SW, Bok AR, et al. Sarcopenia and sarcopenic obesity and their association with dyslipidemia in Korean elderly men: the 2008-2010 Korea National Health and nutrition examination survey. J Endocrinol Investig. 2014;37:247\u201360.","journal-title":"J Endocrinol Investig"},{"key":"1014_CR4","doi-asserted-by":"publisher","first-page":"e112718","DOI":"10.1371\/journal.pone.0112718","volume":"9","author":"S Ishii","year":"2014","unstructured":"Ishii S, Tanaka T, Akishita M, Ouchi Y, Tuji T, Iijima K, et al. Metabolic syndrome, sarcopenia and role of sex and age: cross-sectional analysis of Kashiwa cohort study. PLoS One. 2014;9:e112718.","journal-title":"PLoS One"},{"key":"1014_CR5","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/ejcn.2012.43","volume":"66","author":"K Sanada","year":"2012","unstructured":"Sanada K, Iemitsu M, Murakami H, Gando Y, Kawano H, Kawakami R, et al. Adverse effects of coexistence of sarcopenia and metabolic syndrome in Japanese women. Eur J Clin Nutr. 2012;66:1093\u20138.","journal-title":"Eur J Clin Nutr"},{"key":"1014_CR6","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1146\/annurev.bi.49.070180.003315","volume":"49","author":"P Nilssonehle","year":"1980","unstructured":"Nilssonehle P, Garfinkel AS, Schotz MC. Lipolytic enzymes and plasma lipoprotein metabolism. Annu Rev Biochem. 1980;49:667\u201393.","journal-title":"Annu Rev Biochem"},{"key":"1014_CR7","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.bbalip.2014.03.013","volume":"1841","author":"S Kersten","year":"2014","unstructured":"Kersten S. Physiological regulation of lipoprotein lipase. Biochim Biophys Acta. 2014;1841:919\u201333.","journal-title":"Biochim Biophys Acta"},{"key":"1014_CR8","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.tem.2016.04.013","volume":"27","author":"LG Fong","year":"2016","unstructured":"Fong LG, Young SG, Beigneux AP, Bensadoun A, Oberer M, Jiang H, et al. GPIHBP1 and plasma triglyceride metabolism. Trends Endocrinol Metab. 2016;27:455\u201369.","journal-title":"Trends Endocrinol Metab"},{"key":"1014_CR9","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.bbalip.2011.09.008","volume":"1821","author":"JD Brunzell","year":"2012","unstructured":"Brunzell JD, Zambon A, Deeb SS. The effect of hepatic lipase on coronary artery disease in humans is influenced by the underlying lipoprotein phenotype. Biochim Biophys Acta. 2012;1821:365\u201372.","journal-title":"Biochim Biophys Acta"},{"key":"1014_CR10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1161\/CIRCGENETICS.109.908905","volume":"3","author":"R Franssen","year":"2010","unstructured":"Franssen R, Young SG, Peelman F, Hertecant J, Sierts JA, Schimmel AWM, et al. Chylomicronemia with low postheparin lipoprotein lipase levels in the setting of GPIHBP1 defects. Circ Cardiovasc Genet. 2010;3:169\u201378.","journal-title":"Circ Cardiovasc Genet"},{"key":"1014_CR11","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1194\/jlr.M002717","volume":"51","author":"G Olivecrona","year":"2010","unstructured":"Olivecrona G, Ehrenborg E, Semb H, Makoveichuk E, Lindberg A, Hayden MR, et al. Mutation of conserved cysteines in the Ly6 domain of GPIHBP1 in familial chylomicronemia. J Lipid Res. 2010;51:1535\u201345.","journal-title":"J Lipid Res"},{"key":"1014_CR12","doi-asserted-by":"publisher","first-page":"E1675","DOI":"10.1210\/jc.2011-1444","volume":"96","author":"S Charriere","year":"2011","unstructured":"Charriere S, Peretti N, Bernard S, Di Filippo M, Sassolas A, Merlin M, et al. GPIHBP1 C89F Neomutation and hydrophobic C-terminal domain G175R mutation in two pedigrees with severe hyperchylomicronemia. J Clin Endocrinol Metab. 2011;96:E1675\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"1014_CR13","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/j.1365-2796.2011.02361.x","volume":"270","author":"I Coca-Prieto","year":"2011","unstructured":"Coca-Prieto I, Kroupa O, Gonzalez-Santos P, Magne J, Olivecrona G, Ehrenborg E, et al. Childhood-onset chylomicronaemia with reduced plasma lipoprotein lipase activity and mass: identification of a novel GPIHBP1 mutation. J Intern Med. 2011;270:224\u20138.","journal-title":"J Intern Med"},{"key":"1014_CR14","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s10545-011-9406-5","volume":"35","author":"JJ Rios","year":"2012","unstructured":"Rios JJ, Shastry S, Jasso J, Hauser N, Garg A, Bensadoun A, et al. Deletion of GPIHBP1 causing severe chylomicronemia. J Inherit Metab Dis. 2012;35:531\u201340.","journal-title":"J Inherit Metab Dis"},{"key":"1014_CR15","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCRESAHA.116.305085","volume":"116","author":"AP Beigneux","year":"2015","unstructured":"Beigneux AP, Fong LG, Bensadoun A, Davies BSJ, Oberer M, Gardsvoll H, et al. GPIHBP1 missense mutations often cause Multimerization of GPIHBP1 and thereby prevent lipoprotein lipase binding. Circ Res. 2015;116:624\u201332.","journal-title":"Circ Res"},{"key":"1014_CR16","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1056\/NEJMoa1611930","volume":"376","author":"AP Beigneux","year":"2017","unstructured":"Beigneux AP, Miyashita K, Ploug M, Blom DJ, Ai M, Linton MRF, et al. Autoantibodies against GPIHBP1 as a cause of hypertriglyceridemia. N Engl J Med. 2017;376:1647\u201358.","journal-title":"N Engl J Med"},{"key":"1014_CR17","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1194\/jlr.R100020-JLR200","volume":"43","author":"B Perret","year":"2002","unstructured":"Perret B, Mabile L, Martinez L, Terce F, Barbaras R, Collet X. Hepatic lipase: structure\/function relationship, synthesis, and regulation. J Lipid Res. 2002;43:1163\u20139.","journal-title":"J Lipid Res"},{"key":"1014_CR18","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1089\/10507250252949405","volume":"12","author":"LH Duntas","year":"2002","unstructured":"Duntas LH. Thyroid disease and lipids. Thyroid. 2002;12:287\u201393.","journal-title":"Thyroid."},{"key":"1014_CR19","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1046\/j.1365-2265.2003.01762.x","volume":"58","author":"M Ito","year":"2003","unstructured":"Ito M, Takamatsu J, Matsuo T, Kameoka K, Kubota S, Fukata S, et al. Serum concentrations of remnant-like particles in hypothyroid patients before and after thyroxine replacement. Clin Endocrinol. 2003;58:621\u20136.","journal-title":"Clin Endocrinol"},{"key":"1014_CR20","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1089\/thy.2015.0140","volume":"26","author":"G Brenta","year":"2016","unstructured":"Brenta G, Berg G, Miksztowicz V, Lopez G, Lucero D, Faingold C, et al. Atherogenic lipoproteins in subclinical hypothyroidism and their relationship with hepatic lipase activity: response to replacement treatment with levothyroxine. Thyroid. 2016;26:365\u201372.","journal-title":"Thyroid."},{"key":"1014_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3810\/PSM.2009.04.1678","volume":"37","author":"EP Plaisance","year":"2009","unstructured":"Plaisance EP, Grandjean PW, Mahurin AJ. Independent and combined effects of aerobic exercise and pharmacological strategies on serum triglyceride concentrations: a qualitative review. Phys Sportsmed. 2009;37:11\u20139.","journal-title":"Phys Sportsmed"},{"key":"1014_CR22","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1055\/s-2001-16230","volume":"33","author":"J Kobayashi","year":"2001","unstructured":"Kobayashi J, Saito K, Fukamachi I, Taira K, Takahashi K, Bujo H, et al. Pre-heparin plasma lipoprotein lipase mass: correlation with intra-abdominal visceral fat accumulation. Horm Metab Res. 2001;33:412\u20136.","journal-title":"Horm Metab Res"},{"key":"1014_CR23","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.diabres.2006.08.004","volume":"76","author":"A Saiki","year":"2007","unstructured":"Saiki A, Oyama T, Endo K, Ebisuno M, Ohira M, Koide N, et al. Preheparin serum lipoprotein lipase mass might be a biomarker of metabolic syndrome. Diabetes Res Clin Pract. 2007;76:93\u2013101.","journal-title":"Diabetes Res Clin Pract"},{"key":"1014_CR24","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.diabres.2005.09.016","volume":"72","author":"Y Miyashita","year":"2006","unstructured":"Miyashita Y, Ebisuno M, Ohhira M, Endoh K, Saiki A, Koide N, et al. Enhancement of serum lipoprotein lipase mass levels by intensive insulin therapy. Diabetes Res Clin Pract. 2006;72:61\u20137.","journal-title":"Diabetes Res Clin Pract"},{"key":"1014_CR25","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0021-9150(00)00413-5","volume":"153","author":"T Hitsumoto","year":"2000","unstructured":"Hitsumoto T, Ohsawa H, Uchi T, Noike H, Kanai M, Yoshinuma M, et al. Preheparin serum lipoprotein lipase mass is negatively related to coronary atherosclerosis. Atherosclerosis. 2000;153:391\u20136.","journal-title":"Atherosclerosis."},{"key":"1014_CR26","doi-asserted-by":"publisher","first-page":"163","DOI":"10.5551\/jat.9.163","volume":"9","author":"T Hitsumoto","year":"2002","unstructured":"Hitsumoto T, Yoshinaga K, Aoyagi K, Sakurai T, Kanai M, Uchi T, et al. Association between preheparin serum lipoprotein lipase mass and acute myocardial infarction in Japanese men. J Atheroscler Thromb. 2002;9:163\u20139.","journal-title":"J Atheroscler Thromb"},{"key":"1014_CR27","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1161\/01.ATV.10.4.497","volume":"10","author":"JP Despres","year":"1990","unstructured":"Despres JP, Moorjani S, Lupien PJ, Tremblay A, Nadeau A, Bouchard C. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis. 1990;10:497\u2013511.","journal-title":"Arteriosclerosis."},{"key":"1014_CR28","first-page":"977","volume":"85","author":"JQ Purnell","year":"2000","unstructured":"Purnell JQ, Kahn SE, Albers JJ, Nevin DN, Brunzell JD, Schwartz RS. Effect of weight loss with reduction of intra-abdominal fat on lipid metabolism in older men. J Clin Endocrinol Metab. 2000;85:977\u201382.","journal-title":"J Clin Endocrinol Metab"},{"key":"1014_CR29","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1080\/10408369891234273","volume":"35","author":"PW Connelly","year":"1998","unstructured":"Connelly PW, Hegele RA. Hepatic lipase deficiency. Crit Rev Clin Lab Sci. 1998;35:547\u201372.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"1014_CR30","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0009-8981(99)00105-9","volume":"286","author":"PW Connelly","year":"1999","unstructured":"Connelly PW. The role of hepatic lipase in lipoprotein metabolism. Clin Chim Acta. 1999;286:243\u201355.","journal-title":"Clin Chim Acta"},{"key":"1014_CR31","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1161\/hc5001.100795","volume":"104","author":"KA Dugi","year":"2001","unstructured":"Dugi KA, Brandauer K, Schmidt N, Nau B, Schneider JG, Mentz S, et al. Low hepatic lipase activity is a novel risk factor for coronary artery disease. Circulation. 2001;104:3057\u201362.","journal-title":"Circulation."},{"key":"1014_CR32","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/0009-8981(93)90144-S","volume":"216","author":"J Kobayashi","year":"1993","unstructured":"Kobayashi J, Hashimoto H, Fukamachi I, Tashiro J, Shirai K, Saito Y, et al. Lipoprotein lipase mass and activity in severe hypertriglyceridemia. Clin Chim Acta. 1993;216:113\u201323.","journal-title":"Clin Chim Acta"},{"key":"1014_CR33","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1161\/01.ATV.15.8.1086","volume":"15","author":"P Tornvall","year":"1995","unstructured":"Tornvall P, Olivecrona G, Karpe F, Hamsten A, Olivecrona T. Lipoprotein lipase mass and activity in plasma and their increase after heparin are separate parameters with different relations to plasma lipoproteins. Arterioscler Thromb Vasc Biol. 1995;15:1086\u201393.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1014_CR34","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1194\/jlr.M075432","volume":"58","author":"K Miyashita","year":"2017","unstructured":"Miyashita K, Nakajima K, Fukamachi I, Muraba Y, Koga T, Shimomura Y, et al. A new enzyme-linked immunosorbent assay system for human serum hepatic triglyceride lipase. J Lipid Res. 2017;58:1591\u20137.","journal-title":"J Lipid Res"},{"key":"1014_CR35","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.cca.2015.01.016","volume":"442","author":"T Machida","year":"2015","unstructured":"Machida T, Miyashita K, Sone T, Tanaka S, Nakajima K, Saito M, et al. Determination of serum lipoprotein lipase using a latex particle-enhanced turbidimetric immunoassay with an automated analyzer. Clin Chim Acta. 2015;442:130\u20135.","journal-title":"Clin Chim Acta"},{"key":"1014_CR36","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jacl.2017.10.022","volume":"12","author":"K Miyashita","year":"2018","unstructured":"Miyashita K, Fukamachi I, Nagao M, Ishida T, Kobayashi J, Machida T, et al. An enzyme-linked immunosorbent assay for measuring GPIHBP1 levels in human plasma or serum. J Clin Lipidol. 2018;12:203\u201310.","journal-title":"J Clin Lipidol"},{"key":"1014_CR37","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.cca.2017.11.021","volume":"476","author":"Y Muraba","year":"2018","unstructured":"Muraba Y, Koga T, Shimomura Y, Ito Y, Hirao Y, Kobayashi J, et al. The role of plasma lipoprotein lipase, hepatic lipase and GPIHBP1 in the metabolism of remnant lipoproteins and small dense LDL in patients with coronary artery disease. Clin Chim Acta. 2018;476:146\u201353.","journal-title":"Clin Chim Acta"},{"key":"1014_CR38","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.cca.2017.10.017","volume":"475","author":"M Aruga","year":"2017","unstructured":"Aruga M, Tokita Y, Nakajima K, Kamachi K, Tanaka A. The effect of combined diet and exercise intervention on body weight and the serum GPIHBP1 concentration in overweight\/obese middle-aged women. Clin Chim Acta. 2017;475:109\u201315.","journal-title":"Clin Chim Acta"},{"key":"1014_CR39","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1507\/endocrj.K09E-359","volume":"57","author":"Y Yanagawa","year":"2010","unstructured":"Yanagawa Y, Morimura T, Tsunekawa K, Seki K, Ogiwarao T, Kotajima N, et al. Oxidative stress associated with rapid weight reduction decreases circulating adiponectin concentrations. Endocr J. 2010;57:339\u201345.","journal-title":"Endocr J"},{"key":"1014_CR40","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Fredrickson DS, Levy RI. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499\u2013502.","journal-title":"Clin Chem"},{"key":"1014_CR41","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0021-9150(99)00012-X","volume":"145","author":"H Watanabe","year":"1999","unstructured":"Watanabe H, Miyashita Y, Murano T, Hiroh Y, Itoh Y, Shirai K. Preheparin serum lipoprotein lipase mass level: the effects of age, gender, and types of hyperlipidemias. Atherosclerosis. 1999;145:45\u201350.","journal-title":"Atherosclerosis."},{"key":"1014_CR42","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.cca.2014.10.029","volume":"440","author":"T Shirakawa","year":"2015","unstructured":"Shirakawa T, Nakajima K, Yatsuzuka S-i, Shimomura Y, Kobayashi J, Machida T, et al. The role of circulating lipoprotein lipase and adiponectin on the particle size of remnant lipoproteins in patients with diabetes mellitus and metabolic syndrome. Clin Chim Acta. 2015;440:123\u201332.","journal-title":"Clin Chim Acta"},{"key":"1014_CR43","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.cca.2014.07.020","volume":"440","author":"T Shirakawa","year":"2015","unstructured":"Shirakawa T, Nakajima K, Shimomura Y, Kobayashi J, Stanhope K, Havel P, et al. Comparison of the effect of post-heparin and pre-heparin lipoprotein lipase and hepatic triglyceride lipase on remnant lipoprotein metabolism. Clin Chim Acta. 2015;440:193\u2013200.","journal-title":"Clin Chim Acta"},{"key":"1014_CR44","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1152\/jappl.2000.89.1.176","volume":"89","author":"JS Greiwe","year":"2000","unstructured":"Greiwe JS, Holloszy JO, Semenkovich CF. Exercise induces lipoprotein lipase and GLUT-4 protein in muscle independent of adrenergic-receptor signaling. J Appl Physiol. 2000;89:176\u201381.","journal-title":"J Appl Physiol"},{"key":"1014_CR45","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1113\/jphysiol.2002.016832","volume":"541","author":"H Pilegaard","year":"2002","unstructured":"Pilegaard H, Keller C, Steensberg A, Helge JW, Pedersen BK, Saltin B, et al. Influence of pre-exercise muscle glycogen content on exercise-induced transcriptional regulation of metabolic genes. J Physiol. 2002;541:261\u201371.","journal-title":"J Physiol"},{"key":"1014_CR46","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1055\/s-2005-873020","volume":"27","author":"VB Schrauwen-Hinderling","year":"2006","unstructured":"Schrauwen-Hinderling VB, Hesselink MKC, Moonen-Kornips E, Schaart G, Kooi ME, Saris WHM, et al. Short-term training is accompanied by a down regulation of ACC2 mRNA in skeletal muscle. Int J Sports Med. 2006;27:786\u201391.","journal-title":"Int J Sports Med"},{"key":"1014_CR47","first-page":"E255","volume":"272","author":"RL Seip","year":"1997","unstructured":"Seip RL, Mair K, Cole TG, Semenkovich CF. Induction of human skeletal muscle lipoprotein lipase gene expression by short-term exercise is transient. Am J Phys. 1997;272:E255\u201361.","journal-title":"Am J Phys"},{"key":"1014_CR48","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1096\/fj.03-0428com","volume":"18","author":"K Vissing","year":"2004","unstructured":"Vissing K, Andersen JL, Schjerling P. Are exercise-induced genes induced by exercise? FASEB J. 2004;18:94\u20136.","journal-title":"FASEB J"},{"key":"1014_CR49","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2739\/kurumemedj.53.29","volume":"53","author":"R Mitsuzono","year":"2006","unstructured":"Mitsuzono R, Ube M. Effect of endurance training on blood lipid profiles in adolescent female distance runners. Kurume Med J. 2006;53:29\u201335.","journal-title":"Kurume Med J"},{"key":"1014_CR50","doi-asserted-by":"publisher","first-page":"21","DOI":"10.5551\/jat.2337","volume":"17","author":"M Miyashita","year":"2010","unstructured":"Miyashita M, Eto M, Sasai H, Tsujimoto T, Nomata Y, Tanaka K. Twelve-week jogging training increases pre-heparin serum lipoprotein lipase concentrations in overweight\/obese middle-aged men. J Atheroscler Thromb. 2010;17:21\u20139.","journal-title":"J Atheroscler Thromb"},{"key":"1014_CR51","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0022-2275(20)39682-6","volume":"34","author":"S Kihara","year":"1993","unstructured":"Kihara S, Wolle J, Ehnholm C, Chan L, Oka K. Regulation of hepatic triglyceride lipase by thyroid hormone in HepG2 cells. J Lipid Res. 1993;34:961\u201370.","journal-title":"J Lipid Res"},{"key":"1014_CR52","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruy\u00e8re O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48:16\u201331.","journal-title":"Age Ageing"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-019-1014-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12944-019-1014-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-019-1014-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T07:32:42Z","timestamp":1663227162000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-019-1014-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,4]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1014"],"URL":"https:\/\/doi.org\/10.1186\/s12944-019-1014-7","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,4]]},"assertion":[{"value":"8 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Written informed consent was obtained from all participants. This study was approved by the ethics committee of Gunma University Graduate School of Medicine (Approval number 13\u201336).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"84"}}